The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women

Obesity Clinical Trial

Official title:

The Effects of Overfeeding on Obesity-Prone (OP) and Obesity-Resistant (OR) Women

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00072917
• Other study ID #: OVOPOB DK62874 (complted)
• Secondary ID: DK62874
• Status: Completed
• Phase: N/A
• First received: November 12, 2003
• Last updated: January 15, 2010
• Start date: October 2003
• Est. completion date: June 2008

Study information

• Verified date: January 2010
• Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

This is a longitudinal cohort study of how the responses to a 3 day period of controlled overfeeding relate to subsequent weight gain. We hypothesize that thin individuals are resistant to weight gain because they respond to periods of overfeeding by increasing fat oxidation, reducing food intake, and increasing physical activity relative to those who gain weight over time.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: June 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 25 Years to 35 Years

Eligibility

• Half of the subjects will be women, half will be men,

• age 25-35,

• a range of BMI's from 19-27, for the 'thin subjects' there should be no 1st degree relatives with a BMI>30.

• Subjects should not engage in planned physical activity more than 3 hrs per week.

• For the obesity prone group there should be at least 1 1st degree relative with a BMI>30.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Obesity
• Thinness
• Weight Gain

Locations

Country	Name	City	State
United States	University of Colorado Health Sciences Center	Denver	Colorado

Sponsors (1)

Lead Sponsor	Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States,